High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. (Q34626744)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. |
scientific article |
Statements
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer (English)
Mads H Rasmussen
Niels F Jensen
Maria U Rømer
Tine P Hansen
Lise L Christensen
Jan Lindebjerg
Flemming Hansen
Benny V Jensen
Torben F Hansen
Nils Brünner
Torben F Ørntoft
28 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference